Skip to content

Preventing Perinatal Depression with an App-Based CBT Program

Preventing Perinatal Depression Using an App-based Cognitive Behavioral Therapy Program

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06672432
Enrollment
290
Registered
2024-11-04
Start date
2024-11-30
Completion date
2025-11-30
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease Prevention, Perinatal Depression

Keywords

Perinatal depression, cognitive behavioral therapy, iCBT

Brief summary

The goal of this clinical trial is to learn if CareMom, a mobile app-based cognitive behavioral therapy program works to prevent perinatal depression among Chinese mothers. The main questions the trial aims to answer are: 1. Does CareMom lower depression scores after an 8-week intervention? 2. Does CareMom lower depression scores at 6 weeks after childbirth? 3. How satisfied are participants with CareMom? 4. What unfavorable events, if any, are associated with the use of CareMom? Researchers will compare CareMom to a matched attention control (a mobile app-based program that offers participants a similar level of interaction and daily activities) to see if CareMom works to prevent perinatal depression. Participants will: 1. Engage in the CareMom program or a relaxation training program every day for 8 weeks 2. Complete a series of online questionnaire tests before and after the 8-week intervention. 3. Report any discomfort experienced throughout the study period.

Detailed description

A two-arm parallel randomised controlled trial of 290 pregnant women will be conducted at Jintang County Maternity and Child Health Hospital of Chengdu, China. Eligible women who consent to participate in the trial will be recruited at 20-24 weeks of gestation, and randomly allocated to either the intervention group (participate in a mobile app-based 8-week cognitive behavioral therapy program, named CareMom) or the control group (participate in a mobile app-based, attention-matched, 8-week relaxation training program) using a computer-generated random number. The primary outcomes are the changes in Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire-9 (PHQ-9) and 7-item Generalized Anxiety Disorder (GAD-7) scores from From enrollment to the end of intervention at 8 weeks.

Interventions

OTHERCareMom (a mobile app-based 8-wekk cognitive behavioral therapy program)

The intervention is divided into daily tasks spread across eight weeks, with each day involving a variety of interactive elements such as videos, text-based content, guided reflections, and mental health check-ins. If the user misses a daily challenge, she can complete that challenge in the later days. Each week has a distinct focus that progressively builds the user's skills and understanding in managing emotional health. Tasks are designed to be short yet impactful, aiming to enhance engagement and adherence.

OTHERMatched Attention Control (a mobile app-based 8-week online relaxation training program)

This program is designed to mirror the structure and engagement level of the intervention group, providing participants with a similar amount of interaction and daily activities. Each day, participants in the control group will complete 1-2 daily tasks focused on relaxation techniques, such as breathing exercises, mindfulness meditation, and guided imagery. Each task is brief, approximately 3 minutes in duration, making it easy for participants to incorporate into their daily routine.

Sponsors

Chengdu Women's and Children's Central Hospital
CollaboratorOTHER
Jintang County Maternal and Child Health Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Biostatisticians will be blinded to the study groups, ensuring that all results are analyzed and interpreted without bias.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* aged 18-45 years * at 20-24 weeks of gestation * at risk of depression but not experiencing severe depressive symptoms at recruitment, as indicated by an Edinburgh Postnatal Depression Scale (EPDS) score of between 5 and 12 * own a smartphone * are able to independently engage with the program

Exclusion criteria

* have serious medical conditions or pregnancy complications that may affect their psychological condition, as determined by their medical doctor * have a prior diagnosis of any mental disorders * are currently or were recently (within the past six months) receiving any kinds of psychological services or treatments * have a history of self-harm or suicide * have any suicidal thoughts in the past 12 months * experienced fetal deaths in the past 18 months

Design outcomes

Primary

MeasureTime frameDescription
Changes in depression score at 6 weeks postpartumFrom enrollment to 6 weeks postpartumChanges in Edinburgh Postnatal Depression Scale (EPDS) score. EPDS consists of 10 items rated on a four-point scale from 0 to 3, with a maximum score of 30, where higher scores indicate more severe depressive symptoms. We will use the Chinese version of EPDS in this study.
Changes in anxiety score at 6 weeks postpartumFrom enrollment to 6 weeks postpartumChanges in Generalized Anxiety Disorder 7-item (GAD-7) score. GAD-7 consists of seven items, each rated on a score from 0 to 3. The total score ranges from 0 to 21, with higher scores reflecting more severe anxiety symptoms. In our study, the Chinese version of GAD-7 is applied.

Secondary

MeasureTime frameDescription
Changes in depression score at post-interventionFrom enrollment to the end of intervention at 8 weeksChanges in Edinburgh Postnatal Depression Scale (EPDS) score. EPDS consists of 10 items rated on a four-point scale from 0 to 3, with a maximum score of 30, where higher scores indicate more severe depressive symptoms. We will use the Chinese version of EPDS in this study.
Changes in anxiety score at post-interventionFrom enrollment to the end of intervention at 8 weeksChanges in Generalized Anxiety Disorder 7-item (GAD-7) score. GAD-7 consists of seven items, each rated on a score from 0 to 3. The total score ranges from 0 to 21, with higher scores reflecting more severe anxiety symptoms. In our study, the Chinese version of GAD-7 is applied.
Comparisons of satisfaction levelFrom enrollment to the end of intervention at 8 weeksComparisons of Client Satisfaction Questionnaire (CSQ-8) results between the two groups. CSQ-8 consists of 8 items, resulting in scores that range from 8 to 32, with each item evaluated on a Likert scale; higher scores reflect greater levels of satisfaction.
Comparisons of adverse eventsFrom enrollment to the end of intervention at 8 weeksComparisons of adverse events between the two groups

Countries

China

Contacts

Primary ContactChunrong Li, PhD
cdlcr@163.com+8618084859927

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026